Diagnos (TSE:ADK)
:ADK
Want to see TSE:ADK full AI Analyst Report?
Total Valuation
Diagnos has a market cap or net worth of C$22.88M. The enterprise value is C$25.03M.
Market CapC$22.88M
Enterprise ValueC$25.03M
Share Statistics
Diagnos has 120,412,550 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding120,412,550
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Diagnos’s return on equity (ROE) is -6.63 and return on invested capital (ROIC) is -204.11%.
Return on Equity (ROE)-6.63
Return on Assets (ROA)-1.91
Return on Invested Capital (ROIC)-204.11%
Return on Capital Employed (ROCE)-4.67
Revenue Per Employee4.09K
Profits Per Employee-284.70K
Employee Count16
Asset Turnover0.03
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Diagnos is ―. Diagnos’s PEG ratio is 0.49.
PE Ratio―
PS Ratio453.09
PB Ratio43.19
Price to Fair Value43.19
Price to FCF-7.40
Price to Operating Cash Flow-6.20
PEG Ratio0.49
Income Statement
In the last 12 months, Diagnos had revenue of 65.48K and earned -4.56M in profits. Earnings per share was -0.04.
Revenue65.48K
Gross Profit-119.45K
Operating Income-4.26M
Pretax Income-4.56M
Net Income-4.56M
EBITDA-4.13M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -3.78M and capital expenditures -10.80K, giving a free cash flow of -3.79M billion.
Operating Cash Flow-3.78M
Free Cash Flow-3.79M
Free Cash Flow per Share-0.03
Dividends & Yields
Diagnos pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change0.00%
50-Day Moving Average0.23
200-Day Moving Average0.29
Relative Strength Index (RSI)40.17
Average Volume (3m)342.67K
Important Dates
Diagnos upcoming earnings date is Aug 20, 2026, TBA (Confirmed).
Last Earnings DateJun 11, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
Diagnos as a current ratio of 1.49, with Debt / Equity ratio of 133.68%
Current Ratio1.49
Quick Ratio1.49
Debt to Market Cap0.04
Net Debt to EBITDA-0.26
Interest Coverage Ratio-11.06
Taxes
In the past 12 months, Diagnos has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Diagnos EV to EBITDA ratio is -7.44, with an EV/FCF ratio of -7.67.
EV to Sales469.76
EV to EBITDA-7.44
EV to Free Cash Flow-7.67
EV to Operating Cash Flow-7.70
Balance Sheet
Diagnos has C$3.40M in cash and marketable securities with C$2.00M in debt, giving a net cash position of C$1.40M billion.
Cash & Marketable SecuritiesC$3.40M
Total DebtC$2.00M
Net CashC$1.40M
Net Cash Per ShareC$0.01
Tangible Book Value Per Share<C$0.01
Margins
Gross margin is -2090.86%, with operating margin of -6510.62%, and net profit margin of -6956.95%.
Gross Margin-2090.86%
Operating Margin-6510.62%
Pretax Margin-6956.95%
Net Profit Margin-6956.95%
EBITDA Margin-6312.90%
EBIT Margin-6510.62%
Analyst Forecast
The average price target for Diagnos is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-36.92%
EPS Growth Forecast13.03%